Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access type 2 diabetes specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
Canagliflozin is an oral drug which is currently approved for use in patients with type 2 diabetes by the US Food and Drug Administration (FDA). Canagliflozin acts by increasing salt and sugar loss in the urine, and has shown to protect heart, kidney, and blood vessel function in patients with type 2 diabetes. However, it is unknown how canagliflozin protects the kidneys from disease. Therefore, this study plans to learn more about how canagliflozin works to protect against diabetic kidney disea
Sponsor: University of Colorado, Denver
Check if you qualify for this type 2 diabetes clinical trial in Aurora, CO
If you're searching for type 2 diabetes treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.